Partner Headlines - ESRX

  1. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319

    IBD
  2. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  3. Are These Drugstore Retailers Good Investments?

    GuruFocus
  4. AmerisourceBergen a Key Player in the Pharma Industry

    GuruFocus
  5. Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI

    GuruFocus
  6. 5 Stock-Moving Medtech Events This December

    IBD
  7. Top 4 Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  8. Surprisingly, Warren Buffett Buys These 8 Dividend Stocks

    GuruFocus
  9. Warren Buffett and CIOs Buy DirecTV, Charter Communications, ...

    GuruFocus
  10. Scour Mutual Fund Special Sections For Great Ideas

    IBD
  11. Buybacks-Driven Market: Engineered Too Far?

    YCharts
  12. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond ...

    Benzinga
  13. Express Scripts Posts EPS In-line With Estimates

    Benzinga
  14. Stocks Tack On Gains; Centene Hits New High

    IBD
  15. AmerisourceBergen's Move To Go Big Is The Right Rx

    IBD
  16. 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS ...

    Benzinga
  17. These 3 Upcoming IPOs Have Strong Investor Interest

    IBD
  18. IPO Calendar: HubSpot, Dave & Buster's Among 8 IPOs

    IBD
  19. 2 Mutual Funds Holding Hospital Stocks

    Benzinga
  20. UPDATE: Goldman Sachs Downgrades Express Scripts Holding Company

    Benzinga
  21. Benzinga's Top Downgrades

    Benzinga
  22. Goldman Sachs Downgrades Express Scripts To Neutral

    Benzinga
  23. Air Methods Navigates To Grow Medical Flight Business

    IBD
  24. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  25. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  26. The Stocks Already in Correction Mode

    FoxBusiness
  27. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  28. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  29. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating ...

    Benzinga
  30. Earnings Scheduled For July 29, 2014

    Benzinga
  31. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  32. Is Walgreen Set For A Better 2014?

    GuruFocus
  33. Morning Market Losers

    Benzinga
  34. Benzinga's Top #PreMarket Losers

    Benzinga
  35. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  36. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  37. #PreMarket Primer: Friday, July 18: Tension Between Russia And ...

    Benzinga
  38. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  39. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  40. Mid-Year Report Part Two: Not All Stocks Overpriced

    YCharts
  41. Walgreen, Rite Aid Comp Sales Beat On Pharmacies

    IBD
  42. Market Rarity: Great Company at Very Good Price

    YCharts
  43. Weekly CEO Sells Highlight: Installed Building Products Inc, ...

    GuruFocus
  44. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  45. Rite Aid Lowers Outlook On Drug Costs; Shares Fall

    IBD
  46. Walgreen Soars On Bigger Baskets, Scripts In May

    IBD
  47. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  48. Walgreen Hits Record Close On Sweet Easter Sales

    IBD
  49. Walgreen Shares Climb Sharply in Holiday-Lifted April

    IBD
  50. Novo Nordisk lowers outlook

    IBD
  51. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  52. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  53. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  54. CVS Retail, Buyback Expected To Boost Q1 Earnings

    IBD
  55. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  56. Morning Market Losers

    Benzinga
  57. Stock Futures Drag Toward Open; Twitter, VistaPrint Tumble

    IBD
  58. Benzinga's Top #PreMarket Losers

    Benzinga
  59. Market Wrap For April 29: Dow Approaches Record Highs Despite ...

    Benzinga
  60. #PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against ...

    Benzinga
  61. AbbVie Beats Q1 Estimates, Downplays HCV 'Price War'

    IBD
  62. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  63. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  64. UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts

    IBD
  65. Funds Buying UnitedHealth: Stunning Div Growth

    YCharts
  66. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  67. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  68. Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI

    GuruFocus
  69. Google, Ebay: Why A Top Mutual Fund Likes Them

    IBD
  70. Top 4 Large-Cap Stocks In The Health Care Plans Industry With ...

    Benzinga
  71. UPDATE: Morgan Stanley Reiterates on Express Scripts Following ...

    Benzinga
  72. Stock Market Erases Gains, Closes With Losses

    IBD
  73. Stocks Advance In Big Trade; Spirit, Priceline Climb

    IBD
  74. EXPRESS SCRIPTS

    IBD
  75. Earnings Scheduled For February 20, 2014

    Benzinga
  76. Morgan Stanley Feels Confident About Express Scripts Holding ...

    Benzinga
  77. Revenue Growth + Sane Valuation: Making A List

    YCharts
  78. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  79. Double Downside Protection: Moat + Value Pricing

    YCharts
  80. Express Scripts Names Cathy R. Smith CFO

    Benzinga
  81. Investors Stick With Health Care Stocks

    FoxBusiness
  82. McKesson, Cardinal, Amerisource Up Drug-Dealing Ante

    IBD
  83. Walgreen Hurt By Generic Drug Slowdown, Sees '14 Lift

    IBD
  84. S&P Stocks Hitting New Highs

    FoxBusiness
  85. Gilead's Next Hepatitis C Drug A Hit In Trials

    IBD
  86. UPDATE: Morgan Stanley Removes PT on Express Scripts on Management ...

    Benzinga
  87. Walgreen, Rite Aid To Get Drugstore Earnings Checkups

    IBD
  88. UPDATE: Morgan Stanley Reiterates on Express Scripts on Potential ...

    Benzinga
  89. RainTree Oncology Services Announces Distribution Agreement with ...

    Benzinga
  90. Gilead knocked on drug price

    IBD
  91. Gilead HCV Drug May Face Price War; Rival AbbVie Up

    IBD
  92. Health Care ETFs After Obamacare (IHF, XLV, UNH, ESRX)

    Benzinga
  93. RT Oncology Services Joins Express Scripts Pharmacy Network

    Benzinga
  94. ETFs to Buy During Market Pullback (FDN, IHF, GOOG, AMZN, UNH)

    Benzinga
  95. Warrior Capital's Major Sells in Review - VistaPrint, Google, ...

    GuruFocus
  96. Walgreen Takes Some Steps In New Direction

    IBD
  97. UPDATE: Deutsche Bank Initiates Coverage on Express Scripts Holding ...

    Benzinga
  98. Big Surprise While Hunting Bargains: Uncle Warren

    YCharts
  99. Stocks Rise In Mixed Trade; Deckers Outdoor Leaps On Q3 Win

    IBD
  100. Benzinga's Top #PreMarket Losers

    Benzinga
Trading Center